
Amlodipine and Olmesartan Medoxomil Tablets
Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets (10 mg/20 mg) due to failed dissolution specifications.
Contact your healthcare provider or pharmacist to discuss alternative treatment options. Do not stop taking your medication without consulting a medical professional.
Why it was recalled
Ascend Laboratories is recalling Amlodipine and Olmesartan Medoxomil Tablets due to failed dissolution specifications and Olmesartan Medoxomil content that is below required specifications. This recall affects the 10 mg/20 mg strength in 30-count bottles.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Amlodipine and Olmesartan Medoxomil Tablets
- Strength
- 10 mg
- NDC / UPC
- NDC 67877-500-30
Official source
Other recent recalls from Ascend Laboratories, LLC
Editorial summary by Recall Canary · last updated 2026-07-21 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
